Absent T Lymphocytes

Search Trials
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
Status:
Recruiting
Last Changed:
May 5, 2021
First Changed:
Feb 21, 2019
Disease(s):
Melanoma
Intervention(s):
XmAb®22841Pembrolizumab (Keytruda®)
⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin’s Lymphoma
Status:
Completed
Last Changed:
Sep 18, 2018
First Changed:
Apr 11, 2017
Disease(s):
Positron-Emission Tomography
Intervention(s):
⁸⁹Zr-Df-IAB22M2C Infusion
Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
Status:
Completed
Last Changed:
May 18, 2012
First Changed:
Aug 31, 2001
Disease(s):
HIV Infections
Intervention(s):
ALVAC(2)120(B,MN)GNP (vCP1452)gp160 MN/LAI-2ALVAC(1)120(B,MN)GNP (vCP1433)ALVAC-HIV MN120TMG (vCP205)ALVAC-RG Rabies Glycoprotein (vCP65)
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
Status:
Completed
Last Changed:
Nov 4, 2019
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
filgrastimrecombinant interferon alfasargramostimtherapeutic autologous lymphocytescarmustinecyclophosphamideetoposidegemcitabine hydrochloridemelphalanbone marrow ablation with stem cell supportin vitro-treated peripheral blood stem cell transplantation
Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Status:
Terminated
Last Changed:
Jul 20, 2011
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
sargramostimtherapeutic allogeneic lymphocytesallogeneic bone marrow transplantationin vitro-treated bone marrow transplantation

Connect. Empower. Inspire.